The Use of Impella RP Support System in Patients With Right Heart Failure
NCT01777607 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2013-05-14
Summary
The use of Impella RP is safe, feasible and provides a hemodynamic benefit in patients with right ventricular failure.
Conditions
- Right Heart Failure
Interventions
- DEVICE
-
IMPELLA® RP
Sponsors & Collaborators
-
Abiomed Inc.
lead INDUSTRY
Principal Investigators
-
William O.Neill, MD · Henry Ford Hospital
-
Mark Anderson, MD · Albert Einstein Medical Center
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-05-31
- Primary Completion
- 2015-12-31
- Completion
- 2016-06-30
Countries
- United States
Study Locations
More Related Trials
-
PPCM Observational Study (Peripartum Cardiomyopathy)
NCT04234659 ·Status: COMPLETED
-
Reprieve System Pilot Study
NCT06272734 ·Status: RECRUITING ·Phase: NA
-
Rivet PVS Therapy in Group 2 PH-HFpEF
NCT05205265 ·Status: WITHDRAWN ·Phase: NA
-
Cardiac Resynchronization Therapy in Congenital Heart Diseases With Systemic Right Ventricle
NCT04842851 ·Status: COMPLETED
-
Infective Endocarditis in Percutaneous Pulmonary Revalvulation: Comparison Between Melody and Sapien Valves
NCT06186258 ·Status: COMPLETED
-
Rivet PVS Therapy in Group 2 PH-HFpEF Canada
NCT05332873 ·Status: WITHDRAWN ·Phase: NA
-
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management
NCT01452802 ·Status: COMPLETED
-
QuickFlex Micro Left Ventricular Lead Post Approval Study
NCT01179477 ·Status: COMPLETED
-
FAST PV and mGFR™ Technology in Congestive Heart Failure
NCT03808948 ·Status: COMPLETED ·Phase: NA
-
Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT
NCT05524324 ·Status: RECRUITING ·Phase: NA
-
Xeltis Bioabsorbable Pulmonary Valved Conduit Pivotal Study
NCT03022708 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Percutaneous Renal Artery Intervention for Patient With Heart Failure
NCT01403714 ·Status: WITHDRAWN ·Phase: NA
-
The AMPLATZER™ Post-infarct Muscular VSD Occluder Humanitarian Device Exemption (H070005) Post Approval Study
NCT03165526 ·Status: COMPLETED
-
Mitralign Percutaneous Annuloplasty First in Man Study
NCT01852149 ·Status: COMPLETED ·Phase: NA
-
Melody Transcatheter Pulmonary Valve Study: Post Approval Study of the Investigational Device Exemption Cohort
NCT00740870 ·Status: COMPLETED ·Phase: NA
-
SHIELD II Clinical Investigation
NCT02468778 ·Status: TERMINATED ·Phase: NA
-
Melody® Transcatheter Pulmonary Valve Post-Approval Study
NCT01186692 ·Status: COMPLETED ·Phase: NA
-
Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.
NCT02574650 ·Status: UNKNOWN ·Phase: NA
-
Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS
NCT01626079 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Paracor Ventricular Support System (PVSS) for Patients With Heart Failure
NCT00291551 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of Outcomes of CRT and MitraClip for Treatment of Low Ejection Fraction and Functional Mitral Regurgitation in HF
NCT02985268 ·Status: WITHDRAWN ·Phase: NA
-
MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing
NCT02006069 ·Status: TERMINATED ·Phase: NA
-
St. Jude Medical Percutaneous Mitral Valve Repair Study
NCT01500148 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation
NCT02444338 ·Status: COMPLETED ·Phase: NA
-
Safety Study of the Ventricular Partitioning Device (VPD) Implant System in Heart Failure Patients
NCT00573560 ·Status: COMPLETED ·Phase: PHASE1